Cargando…

Impact of Late Oseltamivir Treatment on Influenza Symptoms in the Outpatient Setting: Results of a Randomized Trial

We conducted a double-blind, randomized trial of 134 outpatients with polymerase chain reaction-confirmed influenza to assess the effects of oseltamivir initiated 48–119 hours after illness onset. Oseltamivir treatment did not reduce illness duration, severity, or duration of virus detection. Howeve...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLean, Huong Q., Belongia, Edward A., Kieke, Burney A., Meece, Jennifer K., Fry, Alicia M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4525010/ https://www.ncbi.nlm.nih.gov/pubmed/26258157 http://dx.doi.org/10.1093/ofid/ofv100

Ejemplares similares

Clinical and virologic outcomes in patients with oseltamivir‐resistant seasonal influenza A (H1N1) infections: results from a clinical trial
por: Dharan, Nila J., et al.
Publicado: (2011)

A cross-sectional analysis of symptom severity in adults with influenza and other acute respiratory illness in the outpatient setting
por: VanWormer, Jeffrey J, et al.
Publicado: (2014)

Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type
por: McLean, Huong Q., et al.
Publicado: (2015)

School absenteeism among school‐aged children with medically attended acute viral respiratory illness during three influenza seasons, 2012‐2013 through 2014‐2015
por: McLean, Huong Q., et al.
Publicado: (2017)

Prediction of serious RSV‐related outcomes in older adults with outpatient RSV respiratory illness during 12 consecutive seasons
por: Kieke, Burney A., et al.
Publicado: (2020)

Effect of Statin Use on Influenza Vaccine Effectiveness
por: McLean, Huong Q., et al.
Publicado: (2016)

Efficacy comparison of oseltamivir alone and oseltamivir-antibiotic combination for early resolution of symptoms of severe influenza-A and influenza-B hospitalized patients
por: Ishaqui, Azfar A., et al.
Publicado: (2020)

Validation of self‐reported influenza vaccination in the current and prior season
por: King, Jennifer P., et al.
Publicado: (2018)

1056 Factors Associated with Pre-season Seroprotection to B Lineage Influenza Viruses in Children
por: King, Jennifer, et al.
Publicado: (2014)

Incidence of Medically Attended Respiratory Syncytial Virus and Influenza Illnesses in Children 6–59 Months Old During Four Seasons
por: Simpson, Melissa D., et al.
Publicado: (2016)

Earliest infections predict the age distribution of seasonal influenza A cases
por: Arevalo, Philip, et al.
Publicado: (2020)

Risk of symptomatic severe acute respiratory syndrome coronavirus 2 infection not associated with influenza vaccination in the 2019–2020 season
por: King, Jennifer P., et al.
Publicado: (2021)

Outpatient Antibiotic Prescribing for Acute Respiratory Infections During Influenza Seasons
por: Havers, Fiona P., et al.
Publicado: (2018)

Hospitalization following outpatient medical care for influenza: US influenza vaccine effectiveness network, 2011‐12—2015‐16
por: Appiah, Grace D., et al.
Publicado: (2018)

Clinical Features, Severity, and Incidence of RSV Illness During 12 Consecutive Seasons in a Community Cohort of Adults ≥60 Years Old
por: Belongia, Edward A, et al.
Publicado: (2018)

Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons
por: McLean, Huong Q., et al.
Publicado: (2014)

1057 Factors Associated with Influenza A (H1N1)pdm09 (pH1N1) Vaccine Failure among Children Aged 5-17 Years
por: Mclean, Huong, et al.
Publicado: (2014)

Interim Estimates of 2022–23 Seasonal Influenza Vaccine Effectiveness — Wisconsin, October 2022–February 2023
por: McLean, Huong Q., et al.
Publicado: (2023)

Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008
por: Irving, Stephanie A., et al.
Publicado: (2011)

Seasonal Incidence of Medically Attended Respiratory Syncytial Virus Infection in a Community Cohort of Adults ≥50 Years Old
por: McClure, David L., et al.
Publicado: (2014)

Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection — Tennessee and Wisconsin, April–September 2020
por: Rolfes, Melissa A., et al.
Publicado: (2021)

Demand for Prophylaxis after Bioterrorism-Related Anthrax Cases, 2001
por: Belongia, Edward A., et al.
Publicado: (2005)

Elementary School-Based Influenza Vaccination: Evaluating Impact on Respiratory Illness Absenteeism and Laboratory-Confirmed Influenza
por: Kjos, Sonia A., et al.
Publicado: (2013)

925. Oseltamivir usage in community settings: data from a household transmission study
por: Mellis, Alexandra, et al.
Publicado: (2023)

Serious outcomes of medically attended, laboratory‐confirmed influenza illness among school‐aged children with and without asthma, 2007‐2018
por: McLean, Huong Q., et al.
Publicado: (2020)

1055 Antibody Response to Intradermal and High Dose Influenza Vaccine in 2012-13 Among Adults Who Did and Did Not Respond to Standard Dose Vaccine in 2011-12
por: Sundaram, Maria, et al.
Publicado: (2014)

Impact of a 24/7 Rapid Molecular Assay for Influenza Detection on the Prescription of Oseltamivir
por: Jacquier, Hervé, et al.
Publicado: (2020)

mRNA COVID‐19 vaccine effectiveness against SARS‐CoV‐2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021
por: McLean, Huong Q., et al.
Publicado: (2022)

991. Randomized Trial of High Dose, Adjuvanted, and Standard Inactivated Influenza Vaccine Immune Response Against Egg- and Cell-Propagated Vaccine Strains in Older Adults, 2016–2017 Season
por: McLean, Huong, et al.
Publicado: (2018)

Impact of Statewide Program To Promote Appropriate Antimicrobial Drug Use
por: Belongia, Edward A., et al.
Publicado: (2005)

Clinician Knowledge and Beliefs after Statewide Program to Promote Appropriate Antimicrobial Drug Use
por: Kiang, Karen M., et al.
Publicado: (2005)

Pharmacokinetics and Pharmacodynamics of Conventional-Dose vs Triple-Dose Oseltamivir in Severely Immunocompromised Children With Influenza
por: Bautista, Francisco, et al.
Publicado: (2019)

Effect of Previous-Season Influenza Vaccination on Serologic Response in Children During 3 Seasons, 2013–2014 Through 2015–2016
por: McLean, Huong Q, et al.
Publicado: (2019)

Adamantane-Resistant Influenza Infection During the 2004–05 Season
por: Rahman, Mahbubur, et al.
Publicado: (2008)

Influenza Vaccine Effectiveness in the United States During the 2016–2017 Season
por: Flannery, Brendan, et al.
Publicado: (2017)

Effectiveness of first and second COVID‐19 mRNA vaccine monovalent booster doses during a period of circulation of Omicron variant sublineages: December 2021–July 2022
por: Petrie, Joshua G., et al.
Publicado: (2023)

Evaluation of Oseltamivir Used to Prevent Hospitalization in Outpatients With Influenza: A Systematic Review and Meta-analysis
por: Hanula, Ryan, et al.
Publicado: (2023)

Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2015
por: Flannery, Brendan, et al.
Publicado: (2015)

Oseltamivir in human avian influenza infection
por: Smith, James R.
Publicado: (2010)

Interim Estimates of 2013–14 Seasonal Influenza Vaccine Effectiveness — United States, February 2014
por: Flannery, Brendan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fr6l5aq0e462logqvdj202hion